Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (IK2CX002729-01A1)
- License Information
-
More Information
Article History
Received: 15 August 2025
Revised: 17 November 2025
Accepted: 24 November 2025
First Online: 9 December 2025
Competing interests
: MFG has been a speaker for Boehringer Ingelheim and Sumitomo Dainippon Pharma. The other authors do not have any conflict of interest.
